# Ligandal: Biotechnology, San Francisco, United States

> Ligandal: Ligandal is a private biotechnology and genetic medicine company founded in 2013 by Andre Watson. Based in San Francisco, United States. Founded 2014.

Source: https://millionrounds.com/startup/ligandal (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Ligandal

Ligandal is a private biotechnology and genetic medicine company founded in 2013 by Andre Watson.

Funding reported Last round: Seed

Biotechnology San Francisco, United States

Company summary

- **Founded:** 2014 12 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** $4.6M in dollars
- **Last round:** Seed Feb 2019

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Ligandal has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Ligandal

Ligandal is a private biotechnology and genetic medicine company founded in 2013 by Andre Watson.

The company focuses on precision targeting and non-viral delivery methods for personalized therapies in gene therapy, gene editing, regenerative medicine, immunotherapy, and pandemic defense applications. Ligandal aims to address diseases at their molecular roots through AI-guided precision targeting and advanced delivery technologies. The core of Ligandal's platform is its Peptide Direct Conjugate (PDC) technology, which is enhanced by LigandAI® and Predictive Interactomics®. This technology has been developed over more than a decade to improve the accuracy and efficiency of targeted therapeutic delivery. Ligandal's offerings include gene therapy delivery technologies, gene editing systems for CRISPR-Cas9, regenerative medicine applications, immunotherapy solutions, and pandemic defense programs, including initiatives focused on COVID-19. The company emphasizes cell-specific and tissue-specific targeting, utilizing computational biology and machine learning to design effective delivery strategies.

## What company datasets say Ligandal raised

Funding, as reported

Reported in all **$4.6M** in dollars

Rounds **7**

Last round **Seed**

Last round size **$1.6M**

Last round date **Feb 2019**

Investors listed **22**

SEC Form D **$148K sold, 3 filings, last Jan 2014**

## On 5 portfolio pages

Investors who name them

- [DEV Capital](https://millionrounds.com/fund/dev-capital)
- [Machina Ventures](https://millionrounds.com/fund/machina-ventures)
- [Mana Industries](https://millionrounds.com/fund/mana-industries)
- [Sommet AB & Sommet Ventures AB](https://millionrounds.com/fund/sommet-ab-and-sommet-ventures-ab)
- [Flucas Ventures](https://millionrounds.com/fund/flucas-ventures)

Each firm lists Ligandal on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

dna delivery ligandai predictive platform ligandai platform molecular engineering tools health care cell surface receptor targeting nanotech in medicine mrna delivery molecular diagnostics research acceleration predictive interactomics research time saved cell-specific delivery medical research information technology & services disease targeting

Built with from their website

Docker Google Cloud C++ Google Workspace CloudFlare Viewport Meta OpenAI Gym PyTorch OpenAI Google Meet

+8 more

CloudFlare CDN Google Font API Cloudflare Insights SAS Mobile Friendly Open Graph jQuery PySpark

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** California
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/ligandal)

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put Ligandal in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)